The report provides an overview of the therapeutics market for colon cancer as well as information on product development, key players and late-stage and discontinued projects. The information in the report was gathered from Global Markets Direct’s proprietary databases, company and university websites, SEC filings, investor presentations and featured news releases.
The full report is available for purchase on the Research and Markets website.
Related Articles on Colon Cancer:
Dr. Patricia Raymond Produces Music Video to Raise Colonoscopy Screening Awareness Among African-American Community
Colon Cancer Alliance Praises FDA’s Biosimilars Guidance
Colorectal Cancer Screening Rates by the Numbers: 12 Recent Statistics
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
